Landos Biopharma Company

Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
Industry: End-to-end Drug Development
Headquarters: Blacksburg, Virginia, United States
Founded Date: 2017-06-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 6
Total Funding: 70000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-08-13
Last Funding Type: Series B

Visit Website
Register and Claim Ownership